Search Results for 'Biologics, Proteins, Vaccines'
Contract Service Directory Companies
Featured Companies
View All Buyers Guide Companies »
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Samsung Bioepis Opens New Headquarters
The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-gen biologic medicines.Tim Wright, Editor, Contract Pharma 01.25.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
AbbVie Licenses ProBioGen’s GlymaxX Technology
Will apply GlymaxX technology to boost the antibody-dependent cell-mediated cytotoxicity (ADCC).Kristin Brooks 01.22.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
CDMO Northway Biotech Expands in U.S.
Opens new biopharmaceutical manufacturing site in greater Boston area.Tim Wright, Editor, Contract Pharma 01.21.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
Nexelis Acquires GSK Vax Lab in Marburg
Enters into a 5-year strategic agreement to support the development of future GSK vaccine candidates.Contract Pharma Staff 01.20.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
JS Bio and Etta Biotech Advancing Partnership
Will set up a high titer transient protein expression platform for high quality protein production.Contract Pharma Staff 01.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Intravacc Completes Project for Provention Bio’s Vax Candidate
Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.Contract Pharma Staff 01.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Cognate BioServices Announces Major Expansion
Will increase cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities and more.Contract Pharma Staff 01.15.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.Contract Pharma Staff 01.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Precision Medicine Group Acquires Project Farma
Adds Project Farma's unique expertise to Precision's suite of end-to-end cell and gene therapy capabilities to support development and commercialization.Contract Pharma Staff 01.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Cytiva Delivers Modular Biologics Factory to Lonza
Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region.Contract Pharma Staff 01.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.Contract Pharma Staff 01.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
RheinCell Therapeutics Achieves GMP Certification
Marks a milestone for the evolution of the company.Contract Pharma Staff 01.13.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
Capricor, Lonza Enter CAP-1002 Development Agreement
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.Contract Pharma Staff 01.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
iosBio Inks Exclusive Vax Platform Pact for COVID-19
OraPro oral delivery vaccine platform technology enables oral administration of thermally-stable, viral vector vaccines.Contract Pharma Staff 01.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Adagene Achieves CAR-T Collaboration Milestone
Yields potential first-ever antibodies targeting human endogenous retrovirus associated with kidney cancer.Contract Pharma Staff 01.12.21
-
Analytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish
A New Era of Vaccine and Biologic Drug Development
As a result of COVID-19, unprecedented investments in vaccines, diagnostics, and treatments have had a tremendous impact on the Biotechnology industry.Online Exclusives Kristin Brooks, Managing Editor 01.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Parenterals
Irisys Receives NIH Contract for the Formulation of Drinabant
Seeks to develop a drug for treatment of acute cannabinoid overdose.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Parenterals
Baxter, Novavax Ink Sterile Manufacturing Agreement
CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
Texas A&M System contract designates the CDMO’s Texas facility for emergency federal use.Contract Pharma Staff 01.11.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Information Technology
Leukocare Starts Operations in the US
Opens development laboratories and offices in Boston area.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
AMRI Included in BARDA CDMO Network
Joins effort to support of COVID-19 pandemic response in the U.S.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Abzena Unveils New Biologics GMP Manufacturing Site
U.S.-based facility will be equipped with up to 12 X 2000L bioreactors.Contract Pharma Staff 01.11.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing
Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals
Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.Contract Pharma Staff 01.08.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Biogen Licenses CEVEC AAV Mfg. Technology
Biogen gains rights to ELEVECTA Technology for manufacturing of gene therapy products.Contract Pharma Staff 01.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
MilliporeSigma Acquires AmpTec
Expands mRNA capabilities for vaccines, treatments and diagnostics.Contract Pharma Staff 01.07.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CureVac and Bayer Join Forces
Collaborate to develop new Covid-19 vaccine candidate CVnCoV.Contract Pharma Staff 01.07.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm to Invest $2B in US Manufacturing Site
Aims to accelerate the growth of its biopharmaceutical contract development and manufacturing business.Contract Pharma Staff 01.07.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Botanical Solution Inc. to Supply Pharma Grade QS-21 Vaccine Adjuvant
Secures $3.3 million in funding with second round planned for Spring 2021 to bolster growth.Contract Pharma Staff 01.06.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
BrickBio Inks ADC Co-Development Deal
To co-develop a therapeutic antibody drug conjugate (ADC) with a large pharmaceutical company.Contract Pharma Staff 01.06.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Emergex Signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz
Agreement provides a framework for future clinical trials, manufacturing, sales and marketing, and distribution within the National Health Service of Brazil.Contract Pharma Staff 01.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Biogen, ViGeneron Enter Gene Therapy Collaboration
Will develop and commercialize gene therapy products based on adeno-associated virus vectors to treat inherited eye diseases.Contract Pharma Staff 01.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Genezen Laboratories Receives Growth Equity Investment
Will fund the completion of the company’s lentiviral vector production facility.Contract Pharma Staff 01.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Akston Biosciences and LakePharma Enter Covid-19 Partnership
Will manufacture second-generation COVID-19 vaccine, AKS-452.Contract Pharma Staff 01.05.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm to Invest $40M in New Facility
State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.Contract Pharma Staff 01.05.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
AGC Biologics Manufactures Orchard Therapeutics' Libmeldy
European Commission approves one-time therapy for early-onset Metachromatic Leukodystrophy, manufactured at AGC's Milan facility.Contract Pharma Staff 01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
Partnership adds Asian manufacturing resource to INOVIO's global manufacturing consortium for INO-4800.Contract Pharma Staff 01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
Lantern Pharma Launches ADC Program
Will leverage RADR artificial intelligence platform to target solid tumors and blood cancers through agreement with Califia Pharma.Contract Pharma Staff 01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement
Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.Contract Pharma Staff 01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
Oncorus to Build GMP Viral Immunotherapy Mfg. Facility
88,000 sq.-ft. facility in Andover, MA will support multi-product pipeline of intratumorally and intravenously administered viral immunotherapies.Contract Pharma Staff 01.04.21
-
Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing
Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Lonza Expands Conjugation Facility in Visp
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.Contract Pharma Staff 12.21.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioNTech, Shanghai Fosun Pharma to Supply COVID-19 Vax to China
Sign an agreement to provide 100 million doses of their BNT162 mRNA-based vaccine candidate in 2021.Contract Pharma Staff 12.18.20
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Process Development | Scale-up/Technology Transfer
CHA Biotech Launches Global CDMO Biz
Matica Biotechnology to construct GMP facility for viral vector production in Texas.Contract Pharma Staff 12.16.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Information Technology | QA/QC
CDMO Cognate BioServices Teams Up with L7 Informatics
To implement L7|ESP for integrated manufacturing and lab operations.Contract Pharma Staff 12.16.20
-
Bio News | Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Collaboration Creates Bio Hub in Northern UK
CDMO Fujifilm Diosynth Biotechnologies is part of Northern Bio-Accelerator Partnership.Contract Pharma Staff 12.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
INOVIO to Develop dMAb COVID Treatments under DARPA Grant
$37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.Contract Pharma Staff 12.15.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly to Acquire Prevail Therapeutics in $1B Deal
Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.Contract Pharma Staff 12.15.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Draper, Kite Ink Strategic Technology Pact
Will leverage Draper’s technologies to enable Kite to improve next-gen cell therapies and increase cell manufacturing throughput.Contract Pharma Staff 12.15.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Pfizer, BioNTech Covid-19 Vax Authorized in the U.S.
First doses to be delivered across the nation today in healthcare facilities.Contract Pharma Staff 12.14.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Orgenesis, Cure Therapeutics Form JV
Aims to advance point-of-care development and commercialization of cell and gene therapies.Contract Pharma Staff 12.10.20
